ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
42 hedge funds and large institutions have $90.6M invested in Oncternal Therapeutics, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
42
Holding in Top 10
1
Calls
$7K
Puts
–
Top Buyers
| 1 | +$18.2M | |
| 2 | +$15.3M | |
| 3 | +$6.28M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.92M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$1.56M |
Top Sellers
| 1 | -$8.83M | |
| 2 | -$239K | |
| 3 | -$119K | |
| 4 |
BlackRock
New York
|
-$34.8K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$29.8K |